Emerging clinical applications of high-intensity focused ultrasound

Review OA: closed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-19 ⓘ

This review examines high-intensity focused ultrasound as a minimally invasive, non-ionizing technology for treating primary and metastatic tumors across neurologic, genitourinary, hepato-pancreato-biliary, musculoskeletal, and oncologic applications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-06 · read from full text ⓘ

This review article examines high-intensity focused ultrasound as a minimally invasive, non-ionizing technology for treating primary tumors and metastatic lesions under imaging guidance. The authors highlight its notable effectiveness across diverse clinical fields, including neurologic, genitourinary, hepato-pancreato-biliary, musculoskeletal, and oncologic applications. While the text outlines the broad emerging utility of HIFU in various organ systems, it does not provide specific data or detailed discussion regarding gynecological conditions such as endometriosis or adenomyosis. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

High-intensity focused ultrasound (HIFU) is a minimally-invasive and non-ionizing promising technology and has been assessed for its role in the treatment of not only primary tumors but also metastatic lesions under the guidance of ultrasound or magnetic resonance imaging. Its performance is notably effective in neurologic, genitourinary, hepato-pancreato-biliary, musculoskeletal, oncologic, and other miscellaneous applications. In this article, we reviewed the emerging technology of HIFU and its clinical applications.
Full text 543 characters · extracted from oa-doi-fallback · click to expand
ABSTRACT High-intensity focused ultrasound (HIFU) is a minimally-invasive and non-ionizing promising technology and has been assessed for its role in the treatment of not only primary tumors but also metastatic lesions under the guidance of ultrasound or magnetic resonance imaging. Its performance is notably effective in neurologic, genitourinary, hepato-pancreato-biliary, musculoskeletal, oncologic, and other miscellaneous applications. In this article, we reviewed the emerging technology of HIFU and its clinical applications. Keywords:

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

High-Intensity Focused Ultrasound Ablation Neoplasms High-Intensity Focused Ultrasound Ablation Humans Magnetic Resonance Imaging, Interventional Neoplasms Ultrasonography, Interventional

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:24:54.379125+00:00
unpaywall
last seen: 2026-10-18T06:28:46.490043+00:00